Nextleaf Solutions Ltd (OILFF) Fair Value & Analysis
Healthcare · US · Market cap $6.1M
Nextleaf Solutions Ltd
OILFF · US
Fair value as of: Jul 31, 2026
From 11 valuation models · updated 11 days ago
Fair value updated Jul 31, 2026, revised from $0.0299 to $0.0283 (−5.5%) since Jun 26, 2026. Share price −5.1% over the past month.
Below-average quality, and screening another 16% overvalued on our models.
What matters now
- The price sits above even our optimistic bull case ($0.0283). The favourable scenario is already priced in.
- Weak quality (43/100) and above fair value at the same time, the margin of safety is missing on both counts.
- The models converge in a tight band ($0.0251 to $0.0283), unusually little disagreement for a valuation.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 31, 2026.
How to read this chart
60‑month range $0.0259 – $0.2355 · fair‑value band $0.0251 – $0.0283 · the $0.0337 price screens above the $0.0283 fair value. Dashed = 300-day average. As of Jul 31, 2026.
Analysis
Nextleaf Solutions Ltd (OILFF) currently trades at $0.0337, while our model-based Fair Value estimate is $0.0283, implying the stock looks roughly 16.0% overvalued today. The Quality Score stands at 43/100 (below-average quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: medium).
Over the trailing twelve months, Nextleaf Solutions Ltd generated revenue of $10.3M at a net margin of -13.9%. Revenue declined 31.5% year over year. It earns a return on equity of -29.3%. Fundamentals as of Jul 31, 2026
Our scenario range runs from $0.0251 (bear case) to $0.0283 (bull case); at $0.0337, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 50% below its 52-week high and 19% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -49% fair-value upside, at -16%, OILFF screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 11 models by family
Widest divergence: DCF Models ($0.0200) versus Multiples ($0.0100). Highest evidence: Growth DCF (80).
Notify me when OILFF reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 31, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 45 · Market factors (momentum, volatility) 24
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Nextleaf Solutions Ltd., a cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada.
Full company description
Nextleaf Solutions Ltd., a cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada. The company is involved in toll processing, bulk ingredient supply, manufacturing and commercialization; extraction, distillation, and purification of CBD oils and THC cannabinoid ingredients, as well as engages in licensed processing activities. It sells its products under Glacial Gold and High Plains brands through distribution channels. The company was formerly known as Legion Metals Corp. and changed its name to Nextleaf Solutions Ltd. Nextleaf Solutions Ltd. was founded in 2015 and is headquartered in Vancouver, Canada.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Nextleaf Solutions Ltd reported revenue of $11.3M in FY2025 versus $3.4M in FY2021, a compound +35.1%/yr. Reported net income was −$163K in FY2025.
OILFF screens 16% overvalued. Compare with Jiangsu Hengrui Pharmaceuticals Co →
Peer Group
Drug Manufacturers - Specialty & Generic · 623 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Drug Manufacturers - Specialty & Generic median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate (as of Jul 31, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co 600276 | ¥53.19 | ¥25.94 | -51% |
| Sun Pharmaceutical Industries Limited SUNPHARMA | ₹1,933 | ₹989.50 | -49% |
| Divi's Laboratories Limited DIVISLAB | ₹7,316 | ₹1,943 | -73% |
| Torrent Pharmaceuticals Limited TORNTPHARM | ₹4,763 | ₹1,329 | -72% |
| PharmaEssentia Corporation 6446 | 1,285 TWD | 221.01 TWD | -83% |
| Cipla Limited CIPLA | ₹1,439 | ₹1,001 | -30% |
| Zydus Lifesciences Limited ZYDUSLIFE | ₹1,151 | ₹703.32 | -39% |
| Lupin Limited LUPIN | ₹2,443 | ₹2,477 | +1% |
| Mankind Pharma Limited MANKIND | ₹2,484 | ₹983.11 | -60% |
| Dr. Reddy's Laboratories Limited DRREDDY | ₹1,211 | ₹874.79 | -28% |
Compare Nextleaf Solutions Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Nextleaf Solutions Ltd (OILFF) overvalued or undervalued?
What is the fair value of OILFF?
What is the quality score of OILFF?
What is the revenue of Nextleaf Solutions Ltd (OILFF)?
What is the net profit margin of OILFF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Nextleaf Solutions Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.